What features are common to both? The similarities in the two conditions may be listed as follows: (1) originally described in France; (2) most cases symptomless; (3) histology uninformative; (4) explanations numerous; (5) cause unknown; (6) recurrence common.
(1) Both conditions were described by Frenchmen over 100 years ago. Today we understand neither. Baron Dupuytren produced a classification of bums which is long forgotten. He is remembered for a peculiar condition of the hand because we have no more suitable name (1834) . Dupuytren disease (what kind of disease?) or Dupuytren contracture (but there may never be any contracture) are meaningless terms-they tell us little except to bring a visual picture to mind (Figs. 1, 2, 3, 4) . Alibert (1806) described keloid in 1825-the fabricated name from Greek meaning 'tumour-like'-although he had already recognized the entity in 1806.
(2) Both conditions are common, most cases are symptomless. Heuston (1963) noted that the incidence of Dupuytren in men aged over 55 years was 10% in the general population, rising to 18% at 75 years. Comparable figures for women were 2% and 7 %. The incidence of keloid is not known with any accuracy.
(3) The histology is uninteresting and uninformative (Figs. 5, 6 ). Cosman et al. (1961) (Skoog, 1948; Hueston, 1963; Stack, 1973) (6) Recurrence after surgical excision is common. With keloid the figure is probably 80 %, for Dupuytren less than 30% (Boyes, 1970) . In all, published papers indicate a rather disquieting and disappointing picture of aetiology and management.
What features are dissimilar? To my mind there are five main dissimilarities in the two conditions, although the evidence is slim and most of it is simple testimony. They are as follows: (1) geography and race; (2) site; (3) age and sex; (4) familial; (5) special factors.
(1) The geographical distributions differ, for Dupuytren seems to be much commoner in White races and keloid a disease of the Negro. There have been very few population studies, so it is difficult to be sure. For instance, Naegeli (1931) (Fig. 7) . Dupuytren, on the other hand, is limited to the palmar fascia, but 5% of those affected will have knuckle pads over the proximal interphalangeal joints of the fingers (Fig.  3) , 5% have plantar nodules, and 3% develop Peyronie's disease of the corpora cavernosa.
(3) Dupuytren is common after the age of 50 years, occurring 'naturally' in more than 10% of the male population of Australia, according to Hueston (1963) , yet keloid, although rare in infants and the very old, may occur at any age. Dupuytren is seen in six men for every woman affected; keloid in slightly more women than men, possibly because of the use of earrings (35 % of all keloids referred to hospital occur in the ear lobes).
(4) Dupuytren seems to be familial in 16%-68 %0 of cases (Boyes, 1970; Early, 1962 (Fig. 8) .
Although a history of specific trauma is uncommon keloid in pierced ears seems to support the current hypothesis. However, it must be pointed out that the interval between cause and effect may be as long as 10 years, which is strange. (Levitt and Gillies, 1942) fashion has moved to simple shaving of the tumour portion, then to skin grafting the site after excision, and now concentrates on such simple measures as constant pressure and the injection of corticosteroids.
Management
Griffith (1966) (1965) had warned of the systemic effects of absorption, which were noted in patients having surface application of triamcinolone under an occlusive dressing. Furthermore, Fisherman (1962) found in 27 patients that triamcinolone acetate caused depressed, non-tender areas in the skin and subcutaneous tissues after injection (similar to the lipodystrophy after insulin injection) and thin atrophic skin. The popularity of vitamin E given systemically (it is unpleasant to take, anyway) has waned. Needless to say, results are disappointing. FIG. 8 Diagram to show percentage incidence offingers affected by Dupuytren, based on a total of 3850 digits (2612 hands) reported by Boyes (1970) group.bmj.com on February 22, 2016 -Published by http://ard.bmj.com/ Downloaded from Surgical excision has something to offer for Dupuytren (Clarkson and Pelley, 1962) provided the contracture has not flexed any single digit quickly or for long. The wide-ranging and radical excision of all the palmar fascia has given way to much more localized removal with, I think, better long-term results. Even so the beneficial effects of operation tend to deteriorate with time; Hueston (1963) found that 69% 'excellent' results had fallen to 49% after 10 years.
Knuckle pads (first described by Garrod in 1904) present no problem unless the extensor tendon is inadvertently damaged during excision by an inexperienced surgeon. Plantar nodules do reasonably well, but patients with Peyronie's disease are usually worse off from excision of the plaques of scar tissue. On the whole, it is wise not to operate on a hand unless there are good indications. Evidence that we observe this rule comes from our own performance. For a district with a population of about 100 000 there should have been 40 operations a year, yet we have treated only 60 patients in 6 years, mostly as out patients (Table) . Masterly inactivity is still the most popular treatment for both conditions. to produce keloid in them without any success. In man proline hydroxylase and collagenase activity in keloid skin are both substantially raised (Chvapil, 1975; Cohen et al., 1975) and it has long been recognized that enzymes such as acid phosphatase, which are found in the skin of normal healing wounds until about three weeks, may still be present in a keloid of many years. Fifteen years ago I transplanted three Dupuytren's specimens from the palm to a subcutaneous pouch at the wrist and within a year all the implants had disappeared. Eleven keloids transplanted from the affected site to the anterior abdominal wall all flattened and softened to become normal skin. In six cases in which the abdominal skin was crossgrafted to the keloid area the skin grafts became keloid (Calnan, 1963) -an indication that keloid is 'site determined'. But of what clinical use is such information?
Perhaps the best hope for the future lies in multidisciplined symposia such as this where ideas can be pooled even if resources cannot. The real difficulty lies in diagnosis, for neither condition has special features of pathology. In this respect, the paucity of publications in the 1970s is indicative of our failure to differentiate one condition from the other. To the pathologist the site of origin is imperative for his written report. 'Dupuytren' in the palm of the hand, 'keloid' elsewhere. For the clinician the same applies.
The other difficulty is that neither keloid nor Dupuytren seem, at least on clinical grounds, to be single disease entities. In many patients Dupuytren is not a progressive condition, while in a few the fingers are pulled down into the palm within a year, are not straightened completely by surgical operation, and palmar thickening recurs shortly. It may also occur, rarely, in rheumatoid arthritis, when the main symptom is inability to flex the fingers. There are keloids which progress in area and protruberance relentlessly, while others remain stationary for years. And why do some keloids itch when first they appear while others do not? 
